{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T23:25:18Z","timestamp":1786922718614,"version":"build-2736575974"},"posted":{"date-parts":[[2026,5,6]]},"group-title":"In Review","reference-count":76,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,4,10]]},"abstract":"<title>Abstract<\/title>\n                <p>\n                  <bold>Background:<\/bold>\n                  Alzheimer's disease (AD) is the most common cause of dementia, characterized by progressive aggregation of misfolded proteins. Accumulation of amyloid-beta (A\u03b2) and hyperphosphorylated tau (p-tau) is the hallmark pathology of AD. Diffusion tensor imaging along the perivascular spaces (DTI-ALPS) has been proposed as an MRI marker related to perivascular diffusivity patterns and has been used in studies of neurodegenerative disease.\n                  <bold>Aims:<\/bold>\n                  This study investigates the association between the association between DTI-ALPS indices, regional amyloid-PET burden, and plasma p-tau181 across the AD spectrum.\n                  <bold>Methods:<\/bold>\n                  Data from 410 individuals was enrolled from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database. DTI-ALPS was used as an imaging proxy related to perivascular diffusivity patterns.\n                  <bold>Results:<\/bold>\n                  Mean DTI-ALPS declined progressively from healthy controls to AD. Moreover, females reflected higher DTI-ALPS indices compared with males. No significant associations were observed between perivascular diffusivity patterns and plasma concentration of p-tau 181 in patients with cognitive decline. In contrast, the global cortical amyloid-PET SUVR was associated with the mean [\u03b2 = -0.163] and right DTI-ALPS indices in the MCI group [\u03b2 = -0.202]. Moreover, we observed stronger associations between DTI-ALPS index and amyloid-PET SUVR in the temporal pole cortex [\u03b2 = -0.199], entorhinal cortex [\u03b2 = -0.224], and parahippocampal gyrus in patients with MCI [\u03b2 = -0.281].\n                  <bold>Conclusions:<\/bold>\n                  Reduced DTI-ALPS indices were associated with increased temporolimbic amyloid deposition, particularly in individuals with MCI. These findings suggest DTI-ALPS-derived perivascular diffusivity as an imaging marker associated with amyloid burden in prodromal AD.\n                <\/p>","DOI":"10.21203\/rs.3.rs-9382890\/v1","type":"posted-content","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T16:35:16Z","timestamp":1778085316000},"source":"Crossref","is-referenced-by-count":0,"title":["DTI-ALPS Is Associated with Temporolimbic Amyloid but Not Plasma p-Tau181 Across the Alzheimer\u2019s Disease Continuum"],"prefix":"10.21203","author":[{"given":"Rasa","family":"Zafari","sequence":"first","affiliation":[{"name":"Tehran University of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Kamroo","sequence":"additional","affiliation":[{"name":"Tehran University of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Taherkhani","sequence":"additional","affiliation":[{"name":"Tehran University of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa","family":"Heidari-Foroozan","sequence":"additional","affiliation":[{"name":"Shahid Beheshti University of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fardin","family":"Nabizdeh","sequence":"additional","affiliation":[{"name":"Iran University of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Hadi","family":"Aarabi","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Bordeaux, CNRS, CEA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"1","key":"ref1","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/ene.13439","article-title":"Alzheimer's disease","volume":"25","author":"Lane CA","year":"2018","unstructured":"Lane, C. A., Hardy, J., & Schott, J. M. (2018). Alzheimer's disease. European Journal Of Neurology, 25(1), 59\u201370. 10.1111\/ene.13439","journal-title":"European Journal Of Neurology"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vhri.2023.09.008","article-title":"Economic Burden of Alzheimer's Disease: A Systematic Review","volume":"40","author":"Tay LX","year":"2024","unstructured":"Tay, L. X., Ong, S. C., Tay, L. J., Ng, T., & Parumasivam, T. (2024). Economic Burden of Alzheimer's Disease: A Systematic Review. Value Health Reg Issues, 40, 1\u201312. 10.1016\/j.vhri.2023.09.008","journal-title":"Value Health Reg Issues"},{"issue":"21","key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232112841","article-title":"Phosphorylated Tau in Alzheimer's Disease and Other Tauopathies","volume":"23","author":"Rawat P","year":"2022","unstructured":"Rawat, P., Sehar, U., Bisht, J., Selman, A., Culberson, J., & Reddy, P. H. (2022). Phosphorylated Tau in Alzheimer's Disease and Other Tauopathies. International Journal Of Molecular Sciences, 23(21). 10.3390\/ijms232112841","journal-title":"International Journal Of Molecular Sciences"},{"issue":"1","key":"ref4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000369101","article-title":"Amyloid-beta: a crucial factor in Alzheimer's disease","volume":"24","author":"Sadigh-Eteghad S","year":"2015","unstructured":"Sadigh-Eteghad, S., Sabermarouf, B., Majdi, A., Talebi, M., Farhoudi, M., & Mahmoudi, J. (2015). Amyloid-beta: a crucial factor in Alzheimer's disease. Medical Principles And Practice : International Journal Of The Kuwait University, Health Science Centre, 24(1), 1\u201310. 10.1159\/000369101","journal-title":"Medical Principles And Practice : International Journal Of The Kuwait University, Health Science Centre"},{"issue":"3","key":"ref5","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41591-020-0755-1","article-title":"Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia","volume":"26","author":"Janelidze S","year":"2020","unstructured":"Janelidze, S., Mattsson, N., Palmqvist, S., Smith, R., Beach, T. G., Serrano, G. E., et al. (2020). Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia. Nature Medicine, 26(3), 379\u2013386. 10.1038\/s41591-020-0755-1","journal-title":"Nature Medicine"},{"issue":"2","key":"ref6","doi-asserted-by":"publisher","first-page":"639","DOI":"10.3233\/jad-180512","article-title":"Quantitative Genetics Validates Previous Genetic Variants and Identifies Novel Genetic Players Influencing Alzheimer's Disease Cerebrospinal Fluid Biomarkers","volume":"66","author":"Ramos de Matos M","year":"2018","unstructured":"Ramos de Matos, M., Ferreira, C., Herukka, S. K., Soininen, H., Janeiro, A., Santana, I., et al. (2018). Quantitative Genetics Validates Previous Genetic Variants and Identifies Novel Genetic Players Influencing Alzheimer's Disease Cerebrospinal Fluid Biomarkers. Journal Of Alzheimer'S Disease, 66(2), 639\u2013652. 10.3233\/jad-180512","journal-title":"Journal Of Alzheimer'S Disease"},{"issue":"4","key":"ref7","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s43587-023-00380-7","article-title":"CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer's disease","volume":"3","author":"Barth\u00e9lemy NR","year":"2023","unstructured":"Barth\u00e9lemy, N. R., Saef, B., Li, Y., Gordon, B. A., He, Y., Horie, K., et al. (2023). CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer's disease. Nat Aging, 3(4), 391\u2013401. 10.1038\/s43587-023-00380-7","journal-title":"Nat Aging"},{"issue":"23","key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252312916","article-title":"Role of Blood P-Tau Isoforms (181, 217, 231) in Predicting Conversion from MCI to Dementia Due to Alzheimer's Disease: A Review and Meta-Analysis","volume":"25","author":"Lombardi G","year":"2024","unstructured":"Lombardi, G., Pancani, S., Manca, R., Mitolo, M., Baiardi, S., Massa, F., et al. (2024). Role of Blood P-Tau Isoforms (181, 217, 231) in Predicting Conversion from MCI to Dementia Due to Alzheimer's Disease: A Review and Meta-Analysis. International Journal Of Molecular Sciences, 25(23). 10.3390\/ijms252312916","journal-title":"International Journal Of Molecular Sciences"},{"issue":"1","key":"ref9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3233\/jad-230799","article-title":"The Associations of Phosphorylated Tau 181 and Tau 231 Levels in Plasma and Cerebrospinal Fluid with Cognitive Function in Alzheimer's Disease: A Systematic Review and Meta-Analysis","volume":"98","author":"Li Z","year":"2024","unstructured":"Li, Z., Fan, Z., & Zhang, Q. (2024). The Associations of Phosphorylated Tau 181 and Tau 231 Levels in Plasma and Cerebrospinal Fluid with Cognitive Function in Alzheimer's Disease: A Systematic Review and Meta-Analysis. Journal Of Alzheimer'S Disease, 98(1), 13\u201332. 10.3233\/jad-230799","journal-title":"Journal Of Alzheimer'S Disease"},{"issue":"2","key":"ref10","doi-asserted-by":"publisher","first-page":"e14458","DOI":"10.1002\/alz.14458","article-title":"Diagnostic accuracy of phosphorylated tau217 in detecting Alzheimer's disease pathology among cognitively impaired and unimpaired: A systematic review and meta-analysis","volume":"21","author":"Khalafi M","year":"2025","unstructured":"Khalafi, M., Dartora, W. J., McIntire, L. B. J., Butler, T. A., Wartchow, K. M., Hojjati, S. H., et al. (2025). Diagnostic accuracy of phosphorylated tau217 in detecting Alzheimer's disease pathology among cognitively impaired and unimpaired: A systematic review and meta-analysis. Alzheimers Dement, 21(2), e14458. 10.1002\/alz.14458","journal-title":"Alzheimers Dement"},{"issue":"5","key":"ref11","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/s1474-4422(20)30071-5","article-title":"Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts","volume":"19","author":"Karikari TK","year":"2020","unstructured":"Karikari, T. K., Pascoal, T. A., Ashton, N. J., Janelidze, S., Benedet, A. L., Rodriguez, J. L., et al. (2020). Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts. Lancet Neurology, 19(5), 422\u2013433. 10.1016\/s1474-4422(20)30071-5","journal-title":"Lancet Neurology"},{"issue":"1","key":"ref12","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13024-017-0206-8","article-title":"Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: pilot case-control studies including patients with Alzheimer's disease and down syndrome","volume":"12","author":"Tatebe H","year":"2017","unstructured":"Tatebe, H., Kasai, T., Ohmichi, T., Kishi, Y., Kakeya, T., Waragai, M., et al. (2017). Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: pilot case-control studies including patients with Alzheimer's disease and down syndrome. Mol Neurodegener, 12(1), 63. 10.1186\/s13024-017-0206-8","journal-title":"Mol Neurodegener"},{"issue":"4","key":"ref13","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.3233\/jad-170810","article-title":"Assay of Plasma Phosphorylated Tau Protein (Threonine 181) and Total Tau Protein in Early-Stage Alzheimer's Disease","volume":"61","author":"Yang CC","year":"2018","unstructured":"Yang, C. C., Chiu, M. J., Chen, T. F., Chang, H. L., Liu, B. H., & Yang, S. Y. (2018). Assay of Plasma Phosphorylated Tau Protein (Threonine 181) and Total Tau Protein in Early-Stage Alzheimer's Disease. Journal Of Alzheimer'S Disease, 61(4), 1323\u20131332. 10.3233\/jad-170810","journal-title":"Journal Of Alzheimer'S Disease"},{"issue":"8","key":"ref14","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.jalz.2018.02.013","article-title":"Plasma phospho-tau181 increases with Alzheimer's disease clinical severity and is associated with tau- and amyloid-positron emission tomography","volume":"14","author":"Mielke MM","year":"2018","unstructured":"Mielke, M. M., Hagen, C. E., Xu, J., Chai, X., Vemuri, P., Lowe, V. J., et al. (2018). Plasma phospho-tau181 increases with Alzheimer's disease clinical severity and is associated with tau- and amyloid-positron emission tomography. Alzheimers Dement, 14(8), 989\u2013997. 10.1016\/j.jalz.2018.02.013","journal-title":"Alzheimers Dement"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/S1474-4422(20)30071-5","article-title":"Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts","volume":"19","author":"Karikari T","year":"2020","unstructured":"Karikari, T., Pascoal, T., Ashton, N., Janelidze, S., Benedet, A., Lantero Rodriguez, J., et al. (2020). Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts. The Lancet Neurology, 19, 422\u2013433. 10.1016\/S1474-4422(20)30071-5","journal-title":"The Lancet Neurology"},{"issue":"3","key":"ref16","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00401-020-02195-x","article-title":"Plasma p-tau181 accurately predicts Alzheimer's disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline","volume":"140","author":"Lantero Rodriguez J","year":"2020","unstructured":"Lantero Rodriguez, J., Karikari, T. K., Su\u00e1rez-Calvet, M., Troakes, C., King, A., Emersic, A., et al. (2020). Plasma p-tau181 accurately predicts Alzheimer's disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline. Acta Neuropathologica, 140(3), 267\u2013278. 10.1007\/s00401-020-02195-x","journal-title":"Acta Neuropathologica"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.arr.2016.09.006","article-title":"Dysfunction of the neurovascular unit in ischemic stroke and neurodegenerative diseases: An aging effect","volume":"34","author":"Cai W","year":"2017","unstructured":"Cai, W., Zhang, K., Li, P., Zhu, L., Xu, J., Yang, B., et al. (2017). Dysfunction of the neurovascular unit in ischemic stroke and neurodegenerative diseases: An aging effect. Ageing Research Reviews, 34, 77\u201387. 10.1016\/j.arr.2016.09.006","journal-title":"Ageing Research Reviews"},{"issue":"20","key":"ref18","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1212\/01.wnl.0000264502.92649.ab","article-title":"Neurovascular unit dysfunction: a vascular component of Alzheimer","volume":"68","author":"Benarroch EE","year":"2007","unstructured":"Benarroch, E. E. (2007). Neurovascular unit dysfunction: a vascular component of Alzheimer. disease? Neurology, 68(20), 1730\u20131732. 10.1212\/01.wnl.0000264502.92649.ab","journal-title":"disease? Neurology"},{"issue":"8","key":"ref19","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nrneurol.2015.119","article-title":"Clearance systems in the brain-implications for Alzheimer disease","volume":"11","author":"Tarasoff-Conway JM","year":"2015","unstructured":"Tarasoff-Conway, J. M., Carare, R. O., Osorio, R. S., Glodzik, L., Butler, T., Fieremans, E., et al. (2015). Clearance systems in the brain-implications for Alzheimer disease. Nat Rev Neurol, 11(8), 457\u2013470. 10.1038\/nrneurol.2015.119","journal-title":"Nat Rev Neurol"},{"issue":"6","key":"ref20","doi-asserted-by":"publisher","first-page":"e3001233","DOI":"10.1371\/journal.pbio.3001233","article-title":"Reduced coupling between cerebrospinal fluid flow and global brain activity is linked to Alzheimer disease-related pathology","volume":"19","author":"Han F","year":"2021","unstructured":"Han, F., Chen, J., Belkin-Rosen, A., Gu, Y., Luo, L., Buxton, O. M., et al. (2021). Reduced coupling between cerebrospinal fluid flow and global brain activity is linked to Alzheimer disease-related pathology. Plos Biology, 19(6), e3001233. 10.1371\/journal.pbio.3001233","journal-title":"Plos Biology"},{"issue":"3","key":"ref21","doi-asserted-by":"publisher","first-page":"206","DOI":"10.7555\/jbr.37.20230264","article-title":"Functional aspects of the brain lymphatic drainage system in aging and neurodegenerative diseases","volume":"38","author":"Chen Y","year":"2024","unstructured":"Chen, Y., He, X., Cai, J., & Li, Q. (2024). Functional aspects of the brain lymphatic drainage system in aging and neurodegenerative diseases. J Biomed Res, 38(3), 206\u2013221. 10.7555\/jbr.37.20230264","journal-title":"J Biomed Res"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"844938","DOI":"10.3389\/fneur.2022.844938","article-title":"Perivascular Spaces, Glymphatic System and MR","volume":"13","author":"Yu L","year":"2022","unstructured":"Yu, L., Hu, X., Li, H., & Zhao, Y. (2022). Perivascular Spaces, Glymphatic System and MR. Frontiers In Neurology, 13, 844938. 10.3389\/fneur.2022.844938","journal-title":"Frontiers In Neurology"},{"issue":"12","key":"ref23","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1007\/s11064-015-1581-6","article-title":"The Glymphatic System: A Beginner's Guide","volume":"40","author":"Jessen NA","year":"2015","unstructured":"Jessen, N. A., Munk, A. S., Lundgaard, I., & Nedergaard, M. (2015). The Glymphatic System: A Beginner's Guide. Neurochemical Research, 40(12), 2583\u20132599. 10.1007\/s11064-015-1581-6","journal-title":"Neurochemical Research"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"767470","DOI":"10.3389\/fneur.2021.767470","article-title":"Perivascular Unit, and Glymphatic System: Role of Aquaporin-4 as the Gatekeeper for Water Homeostasis","volume":"12","author":"Szczygielski J","year":"2021","unstructured":"Szczygielski, J., Kopa\u0144ska, M., Wysocka, A., Oertel, J., Cerebral, & Microcirculation (2021). Perivascular Unit, and Glymphatic System: Role of Aquaporin-4 as the Gatekeeper for Water Homeostasis. Frontiers In Neurology, 12, 767470. 10.3389\/fneur.2021.767470","journal-title":"Frontiers In Neurology"},{"issue":"2","key":"ref25","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1007\/s00330-023-10122-3","article-title":"Glymphatic system impairment in Alzheimer's disease: associations with perivascular space volume and cognitive function","volume":"34","author":"Zhang X","year":"2024","unstructured":"Zhang, X., Wang, Y., Jiao, B., Wang, Z., Shi, J., Zhang, Y., et al. (2024). Glymphatic system impairment in Alzheimer's disease: associations with perivascular space volume and cognitive function. European Radiology, 34(2), 1314\u20131323. 10.1007\/s00330-023-10122-3","journal-title":"European Radiology"},{"issue":"11","key":"ref26","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/s1474-4422(18)30318-1","article-title":"The glymphatic pathway in neurological disorders","volume":"17","author":"Rasmussen MK","year":"2018","unstructured":"Rasmussen, M. K., Mestre, H., & Nedergaard, M. (2018). The glymphatic pathway in neurological disorders. Lancet Neurology, 17(11), 1016\u20131024. 10.1016\/s1474-4422(18)30318-1","journal-title":"Lancet Neurology"},{"issue":"3","key":"ref27","doi-asserted-by":"publisher","first-page":"031915","DOI":"10.1117\/1.NPh.9.3.031915","article-title":"Dynamic infrared imaging of cerebrospinal fluid tracer influx into the brain","volume":"9","author":"Keil SA","year":"2022","unstructured":"Keil, S. A., Braun, M., O'Boyle, R., Sevao, M., Pedersen, T., Agarwal, S., et al. (2022). Dynamic infrared imaging of cerebrospinal fluid tracer influx into the brain. Neurophotonics, 9(3), 031915. 10.1117\/1.NPh.9.3.031915","journal-title":"Neurophotonics"},{"issue":"7","key":"ref28","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1177\/0271678x231156982","article-title":"A SPECT-based method for dynamic imaging of the glymphatic system in rats","volume":"43","author":"Sigurdsson B","year":"2023","unstructured":"Sigurdsson, B., Hauglund, N. L., Lilius, T. O., Mogensen, F. L., Mortensen, K. N., Beschorner, N., et al. (2023). A SPECT-based method for dynamic imaging of the glymphatic system in rats. Journal Of Cerebral Blood Flow And Metabolism, 43(7), 1153\u20131165. 10.1177\/0271678x231156982","journal-title":"Journal Of Cerebral Blood Flow And Metabolism"},{"issue":"8","key":"ref29","doi-asserted-by":"publisher","first-page":"e5132","DOI":"10.1002\/nbm.5132","article-title":"Clinical magnetic resonance imaging evaluation of glymphatic function","volume":"37","author":"Boyd ED","year":"2024","unstructured":"Boyd, E. D., Kaur, J., Ding, G., Chopp, M., & Jiang, Q. (2024). Clinical magnetic resonance imaging evaluation of glymphatic function. Nmr In Biomedicine, 37(8), e5132. 10.1002\/nbm.5132","journal-title":"Nmr In Biomedicine"},{"issue":"3","key":"ref30","doi-asserted-by":"publisher","first-page":"268","DOI":"10.2463\/mrms.rev.2023-0175","article-title":"Diffusion Tensor Image Analysis ALong the Perivascular Space (DTI-ALPS): Revisiting the Meaning and Significance of the Method","volume":"23","author":"Taoka T","year":"2024","unstructured":"Taoka, T., Ito, R., Nakamichi, R., Nakane, T., Kawai, H., & Naganawa, S. (2024). Diffusion Tensor Image Analysis ALong the Perivascular Space (DTI-ALPS): Revisiting the Meaning and Significance of the Method. Magnetic Resonance In Medical Sciences : Mrms : An Official Journal Of Japan Society Of Magnetic Resonance In Medicine, 23(3), 268\u2013290. 10.2463\/mrms.rev.2023-0175","journal-title":"Magnetic Resonance In Medical Sciences : Mrms : An Official Journal Of Japan Society Of Magnetic Resonance In Medicine"},{"issue":"3","key":"ref31","doi-asserted-by":"publisher","first-page":"101322","DOI":"10.1016\/j.neurad.2025.101322","article-title":"Emerging non-invasive MRI techniques for glymphatic system assessment in neurodegenerative disease","volume":"52","author":"Botta D","year":"2025","unstructured":"Botta, D., Hutuca, I., Ghoul, E. E., Sveikata, L., Assal, F., L\u00f6vblad, K. O., et al. (2025). Emerging non-invasive MRI techniques for glymphatic system assessment in neurodegenerative disease. Journal Of Neuroradiology. Journal De Neuroradiologie, 52(3), 101322. 10.1016\/j.neurad.2025.101322","journal-title":"Journal Of Neuroradiology. Journal De Neuroradiologie"},{"issue":"4","key":"ref32","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/s11604-017-0617-z","article-title":"Evaluation of glymphatic system activity with the diffusion MR technique: diffusion tensor image analysis along the perivascular space (DTI-ALPS) in Alzheimer's disease cases","volume":"35","author":"Taoka T","year":"2017","unstructured":"Taoka, T., Masutani, Y., Kawai, H., Nakane, T., Matsuoka, K., Yasuno, F., et al. (2017). Evaluation of glymphatic system activity with the diffusion MR technique: diffusion tensor image analysis along the perivascular space (DTI-ALPS) in Alzheimer's disease cases. Jpn J Radiol, 35(4), 172\u2013178. 10.1007\/s11604-017-0617-z","journal-title":"Jpn J Radiol"},{"issue":"3","key":"ref33","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.62347\/oqre2088","article-title":"Glymphatic system dysfunction in cerebral infarction: advances and perspectives based on DTI-derived ALPS measures","volume":"17","author":"Lin B","year":"2025","unstructured":"Lin, B., Leong, Y. Y., & Mohamad, M. (2025). Glymphatic system dysfunction in cerebral infarction: advances and perspectives based on DTI-derived ALPS measures. Am J Transl Res, 17(3), 1630\u20131642. 10.62347\/oqre2088","journal-title":"Am J Transl Res"},{"issue":"1","key":"ref34","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s10143-025-03877-4","article-title":"Association between perivascular spaces, DTI-derived Indices, and choroid plexus with ventriculomegaly and white matter hyperintensity in idiopathic normal pressure hydrocephalus","volume":"48","author":"He W","year":"2025","unstructured":"He, W., Zhou, X., Chen, Z., Lv, J., Xu, Q., Xia, J., et al. (2025). Association between perivascular spaces, DTI-derived Indices, and choroid plexus with ventriculomegaly and white matter hyperintensity in idiopathic normal pressure hydrocephalus. Neurosurgical Review, 48(1), 701. 10.1007\/s10143-025-03877-4","journal-title":"Neurosurgical Review"},{"issue":"5","key":"ref35","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1002\/jmri.28977","article-title":"Noninvasive Magnetic Resonance Imaging Measures of Glymphatic System Activity","volume":"59","author":"Kamagata K","year":"2024","unstructured":"Kamagata, K., Saito, Y., Andica, C., Uchida, W., Takabayashi, K., Yoshida, S., et al. (2024). Noninvasive Magnetic Resonance Imaging Measures of Glymphatic System Activity. Journal Of Magnetic Resonance Imaging, 59(5), 1476\u20131493. 10.1002\/jmri.28977","journal-title":"Journal Of Magnetic Resonance Imaging"},{"issue":"2","key":"ref36","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.neuroimage.2011.09.015","volume":"62","author":"Jenkinson M","year":"2012","unstructured":"Jenkinson, M., Beckmann, C. F., Behrens, T. E., Woolrich, M. W., & Smith, S. M. (2012). FSL Neuroimage. ;62(2):782\u2013790. doi: 10.1016\/j.neuroimage.2011.09.015.","journal-title":"FSL Neuroimage"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"116137","DOI":"10.1016\/j.neuroimage.2019.116137","article-title":"MRtrix3: A fast, flexible and open software framework for medical image processing and visualisation","volume":"202","author":"Tournier JD","year":"2019","unstructured":"Tournier, J. D., Smith, R., Raffelt, D., Tabbara, R., Dhollander, T., Pietsch, M., et al. (2019). MRtrix3: A fast, flexible and open software framework for medical image processing and visualisation. Neuroimage, 202, 116137. 10.1016\/j.neuroimage.2019.116137","journal-title":"Neuroimage"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.neuroimage.2016.08.016","article-title":"Denoising of diffusion MRI using random matrix theory","volume":"142","author":"Veraart J","year":"2016","unstructured":"Veraart, J., Novikov, D. S., Christiaens, D., Ades-Aron, B., Sijbers, J., & Fieremans, E. (2016). Denoising of diffusion MRI using random matrix theory. Neuroimage, 142, 394\u2013406. 10.1016\/j.neuroimage.2016.08.016","journal-title":"Neuroimage"},{"issue":"5","key":"ref39","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1002\/mrm.26054","article-title":"Gibbs-ringing artifact removal based on local subvoxel-shifts","volume":"76","author":"Kellner E","year":"2016","unstructured":"Kellner, E., Dhital, B., Kiselev, V. G., & Reisert, M. (2016). Gibbs-ringing artifact removal based on local subvoxel-shifts. Magnetic Resonance In Medicine, 76(5), 1574\u20131581. 10.1002\/mrm.26054","journal-title":"Magnetic Resonance In Medicine"},{"issue":"2","key":"ref40","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.neuroimage.2007.12.035","article-title":"Stereotaxic white matter atlas based on diffusion tensor imaging in an ICBM template","volume":"40","author":"Mori S","year":"2008","unstructured":"Mori, S., Oishi, K., Jiang, H., Jiang, L., Li, X., Akhter, K., et al. (2008). Stereotaxic white matter atlas based on diffusion tensor imaging in an ICBM template. Neuroimage, 40(2), 570\u2013582. 10.1016\/j.neuroimage.2007.12.035","journal-title":"Neuroimage"},{"issue":"4","key":"ref41","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.14336\/ad.2023.0321-2","article-title":"Cross-Vendor Test-Retest Validation of Diffusion Tensor Image Analysis along the Perivascular Space (DTI-ALPS) for Evaluating Glymphatic System Function","volume":"15","author":"Liu X","year":"2024","unstructured":"Liu, X., Barisano, G., Shao, X., Jann, K., Ringman, J. M., Lu, H., et al. (2024). Cross-Vendor Test-Retest Validation of Diffusion Tensor Image Analysis along the Perivascular Space (DTI-ALPS) for Evaluating Glymphatic System Function. Aging Dis, 15(4), 1885\u20131898. 10.14336\/ad.2023.0321-2","journal-title":"Aging Dis"},{"issue":"2","key":"ref42","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s00234-023-03270-2","article-title":"Glymphatic imaging: a critical look at the DTI-ALPS index","volume":"66","author":"Ringstad G","year":"2024","unstructured":"Ringstad, G. (2024). Glymphatic imaging: a critical look at the DTI-ALPS index. Neuroradiology, 66(2), 157\u2013160. 10.1007\/s00234-023-03270-2","journal-title":"Neuroradiology"},{"issue":"3","key":"ref43","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.molmed.2019.11.008","article-title":"Glymphatic System Impairment in Alzheimer's Disease and Idiopathic Normal Pressure Hydrocephalus","volume":"26","author":"Reeves BC","year":"2020","unstructured":"Reeves, B. C., Karimy, J. K., Kundishora, A. J., Mestre, H., Cerci, H. M., Matouk, C., et al. (2020). Glymphatic System Impairment in Alzheimer's Disease and Idiopathic Normal Pressure Hydrocephalus. Trends In Molecular Medicine, 26(3), 285\u2013295. 10.1016\/j.molmed.2019.11.008","journal-title":"Trends In Molecular Medicine"},{"issue":"1","key":"ref44","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13195-022-00999-5","article-title":"Loss of perivascular aquaporin-4 localization impairs glymphatic exchange and promotes amyloid \u03b2 plaque formation in mice","volume":"14","author":"Simon M","year":"2022","unstructured":"Simon, M., Wang, M. X., Ismail, O., Braun, M., Schindler, A. G., Reemmer, J., et al. (2022). Loss of perivascular aquaporin-4 localization impairs glymphatic exchange and promotes amyloid \u03b2 plaque formation in mice. Alzheimer'S Research & Therapy, 14(1), 59. 10.1186\/s13195-022-00999-5","journal-title":"Alzheimer'S Research & Therapy"},{"issue":"1","key":"ref45","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13195-024-01612-7","article-title":"Glymphatic system clearance and Alzheimer's disease risk: a CSF proteome-wide study","volume":"17","author":"Cullell N","year":"2025","unstructured":"Cullell, N., Caruana, G., Elias-Mas, A., Delgado-Sanchez, A., Artero, C., Buongiorno, M. T., et al. (2025). Glymphatic system clearance and Alzheimer's disease risk: a CSF proteome-wide study. Alzheimer'S Research & Therapy, 17(1), 31. 10.1186\/s13195-024-01612-7","journal-title":"Alzheimer'S Research & Therapy"},{"issue":"7","key":"ref46","doi-asserted-by":"publisher","first-page":"100156","DOI":"10.1016\/j.tjpad.2025.100156","article-title":"Poor glymphatic function is associated with mild cognitive impairment and its progression to Alzheimer's disease: A DTI-ALPS study","volume":"12","author":"Bao C","year":"2025","unstructured":"Bao, C., Luo, H., Wang, J., Liu, X., Li, Y., Yang, J., et al. (2025). Poor glymphatic function is associated with mild cognitive impairment and its progression to Alzheimer's disease: A DTI-ALPS study. The Journal of Prevention of Alzheimer's Disease, 12(7), 100156. https:\/\/doi.org\/10.1016\/j.tjpad.2025.100156","journal-title":"The Journal of Prevention of Alzheimer's Disease"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"1399943","DOI":"10.3389\/fnagi.2024.1399943","article-title":"Moderating effect of education on glymphatic function and cognitive performance in mild cognitive impairment","volume":"16","author":"Zhou L","year":"2024","unstructured":"Zhou, L., Yang, W., Liu, Y., Zheng, Y., Ge, X., Ai, K., et al. (2024). Moderating effect of education on glymphatic function and cognitive performance in mild cognitive impairment. Frontiers In Aging Neuroscience, 16, 1399943. 10.3389\/fnagi.2024.1399943","journal-title":"Frontiers In Aging Neuroscience"},{"issue":"1","key":"ref48","doi-asserted-by":"publisher","first-page":"26381","DOI":"10.1038\/s41598-024-78132-9","article-title":"Evaluating the robustness of DTI-ALPS in clinical context: a meta-analytic parallel on Alzheimer's and Parkinson's diseases","volume":"14","author":"Costa T","year":"2024","unstructured":"Costa, T., Manuello, J., Premi, E., Mattioli, I., Lasagna, L., Lahoz, C. B., et al. (2024). Evaluating the robustness of DTI-ALPS in clinical context: a meta-analytic parallel on Alzheimer's and Parkinson's diseases. Scientific Reports, 14(1), 26381. 10.1038\/s41598-024-78132-9","journal-title":"Scientific Reports"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.sleep.2024.05.007","article-title":"Diffusion tensor imaging analysis along the perivascular space in the UK biobank","volume":"119","author":"Clark O","year":"2024","unstructured":"Clark, O., Delgado-Sanchez, A., Cullell, N., Correa, S. A. L., Krupinski, J., & Ray, N. (2024). Diffusion tensor imaging analysis along the perivascular space in the UK biobank. Sleep Medicine, 119, 399\u2013405. 10.1016\/j.sleep.2024.05.007","journal-title":"Sleep Medicine"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.neuroscience.2023.04.004","article-title":"Association of Cognition and Brain Reserve in Aging and Glymphatic Function Using Diffusion Tensor Image-along the Perivascular Space (DTI-ALPS)","volume":"524","author":"Hsiao WC","year":"2023","unstructured":"Hsiao, W. C., Chang, H. I., Hsu, S. W., Lee, C. C., Huang, S. H., Cheng, C. H., et al. (2023). Association of Cognition and Brain Reserve in Aging and Glymphatic Function Using Diffusion Tensor Image-along the Perivascular Space (DTI-ALPS). Neuroscience, 524, 11\u201320. 10.1016\/j.neuroscience.2023.04.004","journal-title":"Neuroscience"},{"issue":"8","key":"ref51","doi-asserted-by":"publisher","first-page":"e829","DOI":"10.1212\/wnl.0000000000013215","article-title":"Association of Sleep, Neuropsychological Performance, and Gray Matter Volume With Glymphatic Function in Community-Dwelling Older Adults","volume":"98","author":"Siow TY","year":"2022","unstructured":"Siow, T. Y., Toh, C. H., Hsu, J. L., Liu, G. H., Lee, S. H., Chen, N. H., et al. (2022). Association of Sleep, Neuropsychological Performance, and Gray Matter Volume With Glymphatic Function in Community-Dwelling Older Adults. Neurology, 98(8), e829\u2013e38. 10.1212\/wnl.0000000000013215","journal-title":"Neurology"},{"issue":"1","key":"ref52","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3233\/adr-230143","article-title":"Diffusion Tensor Imaging Along Perivascular Spaces (DTI-ALPS) to Assess Effects of Age, Sex, and Head Size on Interstitial Fluid Dynamics in Healthy Subjects","volume":"8","author":"Ozsahin I","year":"2024","unstructured":"Ozsahin, I., Zhou, L., Wang, X., Garetti, J., Jamison, K., Xi, K., et al. (2024). Diffusion Tensor Imaging Along Perivascular Spaces (DTI-ALPS) to Assess Effects of Age, Sex, and Head Size on Interstitial Fluid Dynamics in Healthy Subjects. J Alzheimers Dis Rep, 8(1), 355\u2013361. 10.3233\/adr-230143","journal-title":"J Alzheimers Dis Rep"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"773951","DOI":"10.3389\/fnagi.2021.773951","article-title":"Diffusion Tensor Imaging Along the Perivascular Space Index in Different Stages of Parkinson's Disease","volume":"13","author":"Ma X","year":"2021","unstructured":"Ma, X., Li, S., Li, C., Wang, R., Chen, M., Chen, H., et al. (2021). Diffusion Tensor Imaging Along the Perivascular Space Index in Different Stages of Parkinson's Disease. Frontiers In Aging Neuroscience, 13, 773951. 10.3389\/fnagi.2021.773951","journal-title":"Frontiers In Aging Neuroscience"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"1570327","DOI":"10.3389\/fnagi.2025.1570327","article-title":"Assessment of the glymphatic dysfunction in amyotrophic lateral sclerosis using the diffusion tensor imaging along the perivascular spaces index: a pilot study","volume":"17","author":"Baek SH","year":"2025","unstructured":"Baek, S. H., Tae, W. S., Park, J. W., & Kim, B. J. (2025). Assessment of the glymphatic dysfunction in amyotrophic lateral sclerosis using the diffusion tensor imaging along the perivascular spaces index: a pilot study. Frontiers In Aging Neuroscience, 17, 1570327. 10.3389\/fnagi.2025.1570327","journal-title":"Frontiers In Aging Neuroscience"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"13872877251377790","DOI":"10.1177\/13872877251377790","article-title":"Gonadal hormones and aquaporin-4: Preclinical insights into glymphatic regulation and amyloid clearance","author":"Sahin MZ","unstructured":"Sahin, M. Z., & Yildirim, A. Gonadal hormones and aquaporin-4: Preclinical insights into glymphatic regulation and amyloid clearance. Journal of Alzheimer\u2019s Disease.0(0):13872877251377790. 10.1177\/13872877251377790","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"e27679","DOI":"10.7554\/eLife.27679","article-title":"Test of the 'glymphatic' hypothesis demonstrates diffusive and aquaporin-4-independent solute transport in rodent brain parenchyma","volume":"6","author":"Smith AJ","year":"2017","unstructured":"Smith, A. J., Yao, X., Dix, J. A., Jin, B-J., & Verkman, A. S. (2017). Test of the 'glymphatic' hypothesis demonstrates diffusive and aquaporin-4-independent solute transport in rodent brain parenchyma. eLife, 6, e27679. 10.7554\/eLife.27679","journal-title":"eLife"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"10546","DOI":"10.3390\/ijms262110546","article-title":"The Glymphatic\u2013Venous Axis in Brain Clearance Failure: Aquaporin-4 Dysfunction, Biomarker Imaging, and Precision Therapeutic Frontiers","volume":"26","author":"Costea D","year":"2025","unstructured":"Costea, D., Nicolaie, D., Tataru, C-I., Toader, C., \u0218erban, M., Covache-Busuioc, R-A., et al. (2025). The Glymphatic\u2013Venous Axis in Brain Clearance Failure: Aquaporin-4 Dysfunction, Biomarker Imaging, and Precision Therapeutic Frontiers. International Journal of Molecular Sciences, 26, 10546. 10.3390\/ijms262110546","journal-title":"International Journal of Molecular Sciences"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"1340706","DOI":"10.3389\/fnagi.2023.1340706","article-title":"Fully synthetic phosphorylated Tau181, Tau217, and Tau231 calibrators for Alzheimer's disease diagnosis","volume":"15","author":"Li X","year":"2023","unstructured":"Li, X., Zeng, H., Durairaj, P., Wen, W., Li, T., Zhao, Y., et al. (2023). Fully synthetic phosphorylated Tau181, Tau217, and Tau231 calibrators for Alzheimer's disease diagnosis. Frontiers In Aging Neuroscience, 15, 1340706. 10.3389\/fnagi.2023.1340706","journal-title":"Frontiers In Aging Neuroscience"},{"issue":"4","key":"ref59","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s00401-022-02408-5","article-title":"Plasma biomarkers for Alzheimer's Disease in relation to neuropathology and cognitive change","volume":"143","author":"Smirnov DS","year":"2022","unstructured":"Smirnov, D. S., Ashton, N. J., Blennow, K., Zetterberg, H., Simr\u00e9n, J., Lantero-Rodriguez, J., et al. (2022). Plasma biomarkers for Alzheimer's Disease in relation to neuropathology and cognitive change. Acta Neuropathologica, 143(4), 487\u2013503. 10.1007\/s00401-022-02408-5","journal-title":"Acta Neuropathologica"},{"issue":"6","key":"ref60","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s00401-018-1932-x","article-title":"Current state of Alzheimer's fluid biomarkers","volume":"136","author":"Molinuevo JL","year":"2018","unstructured":"Molinuevo, J. L., Ayton, S., Batrla, R., Bednar, M. M., Bittner, T., Cummings, J., et al. (2018). Current state of Alzheimer's fluid biomarkers. Acta Neuropathologica, 136(6), 821\u2013853. 10.1007\/s00401-018-1932-x","journal-title":"Acta Neuropathologica"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1002\/mds.30325","article-title":"Impaired Glymphatic Clearance, Measured Using Diffusion Tensor Image Analysis Along the Perivascular Space (DTI-ALPS), is Linked to Poor Cognitive Outcomes in Parkinson's Disease","author":"Zarkali A","year":"2025","unstructured":"Zarkali, A., Thomas, G., Paterson, R., Hannaway, N., Dobreva, I., Heslegrave, A. J., et al. (2025). Impaired Glymphatic Clearance, Measured Using Diffusion Tensor Image Analysis Along the Perivascular Space (DTI-ALPS), is Linked to Poor Cognitive Outcomes in Parkinson's Disease. Movement Disorders. 10.1002\/mds.30325","journal-title":"Movement Disorders"},{"issue":"5","key":"ref62","doi-asserted-by":"publisher","first-page":"3251","DOI":"10.1002\/alz.13789","article-title":"Glymphatic system dysfunction predicts amyloid deposition, neurodegeneration, and clinical progression in Alzheimer's disease","volume":"20","author":"Huang SY","year":"2024","unstructured":"Huang, S. Y., Zhang, Y. R., Guo, Y., Du, J., Ren, P., Wu, B. S., et al. (2024). Glymphatic system dysfunction predicts amyloid deposition, neurodegeneration, and clinical progression in Alzheimer's disease. Alzheimers Dement, 20(5), 3251\u20133269. 10.1002\/alz.13789","journal-title":"Alzheimers Dement"},{"issue":"6","key":"ref63","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1002\/ana.24271","article-title":"Impairment of paravascular clearance pathways in the aging brain","volume":"76","author":"Kress BT","year":"2014","unstructured":"Kress, B. T., Iliff, J. J., Xia, M., Wang, M., Wei, H. S., Zeppenfeld, D., et al. (2014). Impairment of paravascular clearance pathways in the aging brain. Annals Of Neurology, 76(6), 845\u2013861. 10.1002\/ana.24271","journal-title":"Annals Of Neurology"},{"issue":"3","key":"ref64","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","article-title":"Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders","volume":"14","author":"Sweeney MD","year":"2018","unstructured":"Sweeney, M. D., Sagare, A. P., & Zlokovic, B. V. (2018). Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol, 14(3), 133\u2013150. 10.1038\/nrneurol.2017.188","journal-title":"Nat Rev Neurol"},{"issue":"8","key":"ref65","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.1093\/brain\/awaa179","article-title":"Impaired glymphatic function and clearance of tau in an Alzheimer's disease model","volume":"143","author":"Harrison IF","year":"2020","unstructured":"Harrison, I. F., Ismail, O., Machhada, A., Colgan, N., Ohene, Y., Nahavandi, P., et al. (2020). Impaired glymphatic function and clearance of tau in an Alzheimer's disease model. Brain, 143(8), 2576\u20132593. 10.1093\/brain\/awaa179","journal-title":"Brain"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"1609793","DOI":"10.3389\/fnagi.2025.1609793","article-title":"Multimodal DTI-ALPS and hippocampal microstructural signatures unveil stage-specific pathways in Alzheimer's disease progression","volume":"17","author":"Yu P","year":"2025","unstructured":"Yu, P., Shen, L., & Tang, L. (2025). Multimodal DTI-ALPS and hippocampal microstructural signatures unveil stage-specific pathways in Alzheimer's disease progression. Frontiers In Aging Neuroscience, 17, 1609793. 10.3389\/fnagi.2025.1609793","journal-title":"Frontiers In Aging Neuroscience"},{"key":"ref67","first-page":"449","volume-title":"Handbook of Clinical Neurology","author":"Migliaccio R","year":"2022","unstructured":"Migliaccio, R., & Cacciamani, F. (2022). Chapter 25 - The temporal lobe in typical and atypical Alzheimer disease. In G. Miceli, P. Bartolomeo, & V. Navarro (Eds.), Handbook of Clinical Neurology (pp. 449\u2013466). Elsevier."},{"issue":"3","key":"ref68","doi-asserted-by":"publisher","first-page":"547","DOI":"10.3233\/jad-2011-101782","article-title":"Synaptic loss in the inferior temporal gyrus in mild cognitive impairment and Alzheimer's disease","volume":"24","author":"Scheff SW","year":"2011","unstructured":"Scheff, S. W., Price, D. A., Schmitt, F. A., Scheff, M. A., & Mufson, E. J. (2011). Synaptic loss in the inferior temporal gyrus in mild cognitive impairment and Alzheimer's disease. Journal Of Alzheimer'S Disease, 24(3), 547\u2013557. 10.3233\/jad-2011-101782","journal-title":"Journal Of Alzheimer'S Disease"},{"issue":"10","key":"ref69","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1523\/jneurosci.0949-21.2021","article-title":"Medial Temporal Lobe Networks in Alzheimer's Disease: Structural and Molecular Vulnerabilities","volume":"42","author":"Flores R","year":"2022","unstructured":"de Flores, R., Das, S. R., Xie, L., Wisse, L. E. M., Lyu, X., Shah, P., et al. (2022). Medial Temporal Lobe Networks in Alzheimer's Disease: Structural and Molecular Vulnerabilities. Journal Of Neuroscience, 42(10), 2131\u20132141. 10.1523\/jneurosci.0949-21.2021","journal-title":"Journal Of Neuroscience"},{"issue":"2","key":"ref70","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1001\/archneur.1994.00540140051014","article-title":"Neuropathologic changes of the temporal pole in Alzheimer's disease and Pick's disease","volume":"51","author":"Arnold SE","year":"1994","unstructured":"Arnold, S. E., Hyman, B. T., & Van Hoesen, G. W. (1994). Neuropathologic changes of the temporal pole in Alzheimer's disease and Pick's disease. Archives Of Neurology, 51(2), 145\u2013150. 10.1001\/archneur.1994.00540140051014","journal-title":"Archives Of Neurology"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"1402573","DOI":"10.3389\/fnagi.2024.1402573","article-title":"Impairment of entorhinal cortex network activity in Alzheimer's disease","volume":"16","author":"Karimani F","year":"2024","unstructured":"Karimani, F., Asgari Taei, A., Abolghasemi-Dehaghani, M. R., Safari, M. S., & Dargahi, L. (2024). Impairment of entorhinal cortex network activity in Alzheimer's disease. Frontiers In Aging Neuroscience, 16, 1402573. 10.3389\/fnagi.2024.1402573","journal-title":"Frontiers In Aging Neuroscience"},{"issue":"1","key":"ref72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/rlu.0000000000005511","article-title":"Tracer-Separator: A Deep Learning Model for Brain PET Dual-Tracer (18 F-FDG and Amyloid) Separation","volume":"50","author":"Sanaat A","year":"2025","unstructured":"Sanaat, A., Hu, Y., Boccalini, C., Salimi, Y., Mansouri, Z., Teixeira, E. P. A., et al. (2025). Tracer-Separator: A Deep Learning Model for Brain PET Dual-Tracer (18 F-FDG and Amyloid) Separation. Clinical Nuclear Medicine, 50(1), 1\u201310. 10.1097\/rlu.0000000000005511","journal-title":"Clinical Nuclear Medicine"},{"issue":"6","key":"ref73","doi-asserted-by":"publisher","first-page":"913","DOI":"10.2967\/jnumed.109.069088","article-title":"In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18)","volume":"51","author":"Wong DF","year":"2010","unstructured":"Wong, D. F., Rosenberg, P. B., Zhou, Y., Kumar, A., Raymont, V., Ravert, H. T., et al. (2010). In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18). Journal Of Nuclear Medicine, 51(6), 913\u2013920. 10.2967\/jnumed.109.069088","journal-title":"Journal Of Nuclear Medicine"},{"issue":"8","key":"ref74","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/s1474-4422(12)70142-4","article-title":"Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-\u03b2 plaques: a prospective cohort study","volume":"11","author":"Clark CM","year":"2012","unstructured":"Clark, C. M., Pontecorvo, M. J., Beach, T. G., Bedell, B. J., Coleman, R. E., Doraiswamy, P. M., et al. (2012). Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-\u03b2 plaques: a prospective cohort study. Lancet Neurology, 11(8), 669\u2013678. 10.1016\/s1474-4422(12)70142-4","journal-title":"Lancet Neurology"},{"issue":"3","key":"ref75","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/ana.20009","article-title":"Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B","volume":"55","author":"Klunk WE","year":"2004","unstructured":"Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., et al. (2004). Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Annals Of Neurology, 55(3), 306\u2013319. 10.1002\/ana.20009","journal-title":"Annals Of Neurology"},{"issue":"11","key":"ref76","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1016\/j.jalz.2018.01.010","article-title":"CSF biomarkers of Alzheimer's disease concord with amyloid-\u03b2 PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts","volume":"14","author":"Hansson O","year":"2018","unstructured":"Hansson, O., Seibyl, J., Stomrud, E., Zetterberg, H., Trojanowski, J. Q., Bittner, T., et al. (2018). CSF biomarkers of Alzheimer's disease concord with amyloid-\u03b2 PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts. Alzheimers Dement, 14(11), 1470\u20131481. 10.1016\/j.jalz.2018.01.010","journal-title":"Alzheimers Dement"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-9382890\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-9382890\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T22:55:08Z","timestamp":1786920908000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-9382890\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,6]]},"references-count":76,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-9382890\/v1","relation":{},"subject":[],"published":{"date-parts":[[2026,5,6]]},"subtype":"preprint"}}